IL-7 R alpha & TSLP R

IL-7 R alpha & TSLP R 분자 정보

영어 이름Interleukin-7 receptor subunit alpha시판 약물 수0
임상 약물 수8표적 별명Interleukin-7 receptor subunit alpha,Interleukin 7 Receptor Isoform H5-6,CDw127,IL-7R subunit alpha,IL-7RA,IL-7 receptor subunit alpha,CD127 Antigen,IL-7R-Alpha,Interleukin 7 Receptor Alpha Chain,CD127,IL7RA,ILRA,Interleukin-7 Receptor alpha Subunit
최고 연구 개발 단계Phase 2 Clinical
영어 이름Interleukin-7 receptor subunit alpha
표적 별명Interleukin-7 receptor subunit alpha,Interleukin 7 Receptor Isoform H5-6,CDw127,IL-7R subunit alpha,IL-7RA,IL-7 receptor subunit alpha,CD127 Antigen,IL-7R-Alpha,Interleukin 7 Receptor Alpha Chain,CD127,IL7RA,ILRA,Interleukin-7 Receptor alpha Subunit
시판 약물 수0
임상 약물 수8
최고 연구 개발 단계Phase 2 Clinical

IL-7 R alpha & TSLP R 제품 목록

  • 속성

    Protein (3)Cell (1)Kits (1)

  • 제품 라이브러리

    온라인 (5)

  • Human (4)Mouse (1)

  • 태그

    Fc Tag (3)- (2)

  • 마커

    Unconjugated (3)- (2)

IL-7 R alpha & TSLP R분자 배경

TSLP is a pleiotropic cytokine originally characterized as a lymphocyte growth factor. Thymic stromal lymphopoietin (TSLP) is overexpressed in the airways of severe asthmatics and is an upstream cytokine that orchestrates inflammatory responses in asthma. Human TSLP exerts its biological activities by binding to a high-affinity heteromeric receptor complex composed of TSLPR and IL- 7 receptor and initiates signaling in cells co-expressing TSLPR and IL-7R.

IL-7 R alpha & TSLP R분자 별명

IL7Ra,CD127,TSLP R,CRLF2,IL-XR,ILXR,p2RY8,CRLF2 fusion,TSLP receptor,TSLPR,CRL2,CRLF2Y,Cytokine receptor-like 2

임상 약물 정보

영어 이름연구 코드연구 개발 단계회사적응증임상 시험
CYT-107CYT-107; CYT-99-007; rhIL-7Phase 2 ClinicalRevimmune IncCarcinoma, Renal Cell; Carcinoma, Transitional Cell; Catheter-Related Infections; Coronavirus Disease 2019 (COVID-19); Hepatitis B, Chronic; Hepatitis C; HIV Infections; Kidney Neoplasms; Leukemia, Myelogenous, Chronic; Leukemia, Myeloid, Acute; Lymphopenia; Metastatic breast cancer; Multiple Myeloma; Mycobacterium Infections, Nontuberculous; Myelodysplastic Syndromes; Myeloproliferative Disorders; Neuroblastoma; Neuroectodermal Tumors, Primitive, Peripheral; Prostatic Neoplasms; Prostatic Neoplasms, Castration-Resistant; Rhabdomyosarcoma, Alveolar; Rhabdomyosarcoma, Embryonal; Sarcoma; Sarcoma, Kaposi; Sepsis; Shock, Septic; Skin Melanoma; T-Lymphocytopenia, Idiopathic CD4-Positive; Ureteral Neoplasms; Urethral Neoplasms; Urinary Bladder Neoplasms; Urologic Neoplasms
상세
LusvertikimabOSE-127; S-95011; Effi-7; OSE-217Phase 2 ClinicalEffimuneColitis, Ulcerative; Sjogren's Syndrome
상세
Efineptakin alfaTJ-107; GX-I7; NT-I7Phase 2 ClinicalGannex Pharma Co LtdAstrocytoma; Breast Neoplasms; Carcinoma, Merkel Cell; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Colorectal Neoplasms; Coronavirus Disease 2019 (COVID-19); Esophageal Neoplasms; Glioblastoma; Glioma; Gliosarcoma; HIV Infections; Hypopharyngeal Neoplasms; Laryngeal Neoplasms; Leukoencephalopathy, Progressive Multifocal; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Lymphopenia; Melanoma; Multiple Myeloma; Oropharyngeal Neoplasms; Ovarian Neoplasms; Pancreatic Neoplasms; Papillomavirus Infections; Plasmablastic Lymphoma; Prostatic Neoplasms, Castration-Resistant; Sarcoma, Kaposi; Small Cell Lung Carcinoma; Solid tumours; Squamous Cell Carcinoma of Head and Neck; Triple Negative Breast Neoplasms; Urinary Bladder Neoplasms
상세
ASP-9801ASP-9801Phase 1 ClinicalAstellas Pharma IncNeoplasm Metastasis; Neoplasms; Solid tumours
상세
PF-06342674RN-168; PF-6342674; PF-06342674; ZB-168Phase 1 ClinicalPfizer IncDiabetes Mellitus, Type 1; Multiple Sclerosis
상세
CD19-IL7Ra CAR-T cells therapy (Chulalongkorn University)CMD-63; CMD63Phase 1 ClinicalChulalongkorn UniversityPrecursor B-Cell Lymphoblastic Leukemia-Lymphoma; Precursor Cell Lymphoblastic Leukemia-Lymphoma
상세
Loco-regional B7H3 IL-7Ra CAR T Cell therapy(Chulalongkorn University)Phase 1 ClinicalChulalongkorn University, King Chulalongkorn Memorial HospitalBrain Neoplasms; Diffuse Intrinsic Pontine Glioma; Neoplasms; Solid tumours
상세
MDK-703MDK-703Phase 1 ClinicalMedikine IncSolid tumours
상세
  • 분자 정보
  • 제품 목록
  • 임상 약물 정보
문의하기

전화
글로벌: +1 800-810-0816 (무료)
아시아태평양: +86 400-682-2521

주소 서울특별시 송파구 법원로11길 11, 제3층 제비-314,315호